We were proud to take part in the official launch of the 2025 Catalyser programme
May 19, 2025
Pharmidex is excited to support this incredible initiative, which welcomes 8 promising therapeutics companies at (or near) the pre-clinical stage.
Over the next 8 weeks, they’ll sharpen their strategy using the Triple Chasm framework and gain access to a powerful mix of scientific, business, and communication support.
During the launch, our very own
Ash Alavijeh joined
Prabhu Velusami, MD (Johnson & Johnson) and
Daniel Marshall (MSD) in a panel discussion exploring trends and opportunities in the therapeutics landscape.
It was a brilliant exchange of insights that inspired the cohort and sparked new conversations.
As part of the Catalyser package, we’re proud to offer:
🔬 Complimentary CRO services from Pharmidex
🤖 AI innovation support with Asae Biotechnology Consulting
🎤 1:1 storytelling coaching with
Kat Arney
from First Create The Media
Huge thanks to Hertfordshire Futures and Stevenage Bioscience Catalyst for driving this programme and for the opportunity to collaborate with such a forward-thinking ecosystem!
We are delighted to announce the promotion of Dr. Martin Barrett to Chief Business Officer at Pharmidex . Martin brings more than 23 years of experience across the pharmaceutical and drug discovery sectors, combining deep scientific expertise with strategic commercial leadership. Throughout his career, he has played a key role in advancing translational science, building strategic partnerships and supporting innovative drug development programmes. In his new role, Martin will help drive Pharmidex’s continued growth, strengthen collaborations, and expand our capabilities across preclinical pharmacology, toxicology, translational science, and clinical development support. Congratulations to Martin on this well-deserved promotion. We look forward to the continued impact of his leadership across Pharmidex and the wider drug discovery community.
Pharmidex is pleased to announce that Janette Dalay Robertson , Business Development Manager, will be attending the Milner Seminar May 2026 hosted by the Milner Therapeutics Institute at the Jeffrey Cheah Biomedical Centre , Cambridge, on 19 May 2026 from 4:00–5:00pm. The seminar will bring together experts from academia and industry to discuss innovation and collaboration in drug discovery and translational science. Pharmidex will also be exhibiting at the event. Janette will be near the café in the Jeffrey Cheah Biomedical Centre from 11am tomorrow, so if you would like to discuss drug discovery, preclinical development, bioanalysis, or potential collaborations, please feel free to stop by for a chat before the seminar begins. Looking forward to connecting with researchers, biotech innovators, and industry partners throughout the day!
We’re pleased to highlight Gaurang Patel and his extensive expertise in clinical and bioanalytical research. With more than 19 years of experience spanning analytical development, method validation, and regulatory-compliant environments, Gaurang brings deep scientific knowledge and operational leadership to every programme. His commitment to robust analytical methods, laboratory excellence, quality, and compliance continues to support the delivery of reliable, efficient, and audit-ready outcomes across complex research projects. At Pharmidex , we value the experience and dedication that help drive scientific progress and trusted partnerships.
